Results of Port of Tauranga Limited Annual Meeting
At Port of Tauranga Limited’s Annual Shareholder Meeting, held today, shareholders were asked to vote on five resolutions, which were supported by the Board.
As required by NZX Listing Rule 6.1, all voting was conducted by a poll.
The resolutions passed by shareholders were:
•
That Ms Julia Hoare be re-elected as a Director of the company.
•
That Ms Alison Andrew be re-elected as a Director of the company.
•
That Mr Fraser Whineray be elected as a Director of the company.
•
That Sir Robert McLeod KNZM be elected as a Director of the company.
•
To resolve that the Auditor-General be reappointed as Auditor of the company pursuant to section 19 of the Port Companies Act 1988 and that the Directors are authorised to fix the Auditor’s remuneration for the ensuing year.
Detail of the total number of votes cast in person or by a proxy holder are:
Resolution For Against Abstain
That Ms Julia Hoare be re-elected as a Director of the company.
461,155,098
99.09%
4,252,938
0.91%
64,362
That Ms Alison Andrew be re-elected as a Director of the company.
465,294,639
99.97%
133,005
0.03%
44,754
That Mr Fraser Whineray be elected as a Director of the company.
455,102,313
97.78%
10,312,847
2.22%
57,238
That Sir Robert McLeod KNZM be elected as a Director of the company.
455,198,173
97.81%
10,194,073
2.19%
80,152
To resolve that the Auditor-General be reappointed as Auditor of the company pursuant to section 19 of the Port Companies Act 1988 and that the Directors are authorised to fix the Auditor’s remuneration for the ensuing year.
465,202,305
99.99%
68,082
0.01%
197,836
Authority for this announcement
Name of person authorised to make this announcement
Simon Kebbell, Company Secretary
Contact person for this announcement
Simon Kebbell, Company Secretary
Contact phone number
027 482 7510
Contact email address
[email protected]
Date of release through MAP
25/10/2024
The S&P/NZX 50 Index closed at 13,113.19, declining 82.89 points or 0.63%.
Auckland surgical products company is forecasting annual profit of between $2m to $6m.
The cancer diagnostics company is awaiting outcomes of several events.
To join your company account for BusinessDesk and enjoy full access, enter your email and we’ll send you details